Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.12
-4.07%
After-hours: Aug 15, 2025, 07:34 PM EDT
Phio Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 35K | n/a | 1K | 34K | 43K | 47K | 47K | 47K | 46K | 46K | 49K | 52K | 50K | 48K | 47K | 47K |
Gross Profit | n/a | n/a | n/a | -1K | -34K | -13K | -47K | -47K | -47K | -46K | -46K | -49K | -52K | -50K | -48K | -47K | -47K |
Operating Income | n/a | -1.67M | -1.59M | -1.91M | -2.21M | -1.77M | -2.78M | -2.55M | -3.6M | -2.73M | -3.57M | -2.52M | -2.64M | -3.45M | -3.74M | -2.68M | -3.64M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.77M | -1.63M | -1.52M | -1.85M | -2.15M | -1.9M | -2.78M | -2.55M | -3.6M | -2.73M | -3.58M | -2.53M | -2.64M | -3.45M | -3.74M | -2.69M | -3.41M |
Net Income | -1.77M | -1.63M | -1.52M | -1.85M | -2.15M | -1.9M | -2.78M | -2.55M | -3.6M | -2.6M | -3.58M | -2.54M | -2.64M | -3.45M | -3.74M | -2.69M | -3.41M |
Selling & General & Admin | 986K | 689K | 946K | 1.05M | 1.03M | 723K | 968K | 1.16M | 1.47M | 1.12M | 1.06M | 1.22M | 1.05M | 1.66M | 932K | 1.02M | 1.02M |
Research & Development | 886K | 985K | 644K | 866K | 1.15M | 1.01M | 1.81M | 1.38M | 2.13M | 1.61M | 2.51M | 1.3M | 1.59M | 1.79M | 2.81M | 1.66M | 2.62M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 4K | -4K | -2K | n/a | -1K | -5K | -10K | -2K | n/a | n/a | n/a | n/a |
Operating Expenses | 1.87M | 1.67M | 1.59M | 1.91M | 2.17M | 1.73M | 2.78M | 2.55M | 3.6M | 2.73M | 3.57M | 2.52M | 2.64M | 3.45M | 3.74M | 2.68M | 3.64M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5K | 10K | 2K | 1K | 3K | 3K | 2K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -34K | -43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 1.67M | 1.59M | 1.91M | 2.21M | 1.77M | 2.78M | 2.55M | 3.6M | 2.73M | 3.57M | 2.52M | 2.64M | 3.45M | 3.74M | 2.68M | 3.64M |
Income Tax Expense | n/a | 9.28K | n/a | n/a | -9.28K | 51K | n/a | n/a | 5.42K | -136K | 5K | 10K | 2K | -9K | -29K | n/a | n/a |
Shares Outstanding (Basic) | 43.07 | 7.87M | 990.03K | 510.19K | 508.39K | 415.95K | 270.86K | 191.86K | 126.78K | 126.43K | 126.38K | 126.34K | 125.47K | 125.19K | 125.19K | 125.19K | 98.79K |
Shares Outstanding (Diluted) | 43.07 | 7.87M | 990.03K | 510.19K | 508.39K | 415.95K | 270.86K | 191.86K | 126.78K | 126.43K | 126.38K | 126.34K | 125.47K | 125.19K | 125.19K | 125.19K | 98.79K |
EPS (Basic) | -41.07K | -0.37 | -1.54 | -3.62 | -4.24 | -4.56 | -10.26 | -13.29 | -28.41 | -20.52 | -28.33 | -20.11 | -21.07 | -27.57 | -29.89 | -21.46 | -34.49 |
EPS (Diluted) | -41.07K | -0.37 | -1.54 | -3.62 | -4.24 | -4.56 | -10.26 | -13.29 | -28.41 | -20.52 | -28.33 | -20.11 | -21.07 | -27.57 | -29.89 | -21.46 | -34.49 |
EBITDA | n/a | -1.67M | -1.59M | -1.84M | -2.17M | -1.69M | -2.73M | -2.5M | -3.56M | -2.69M | -3.53M | -2.48M | -2.59M | -3.43M | -3.72M | -2.67M | -3.62M |
EBIT | n/a | -1.67M | -1.59M | -1.91M | -2.21M | -1.77M | -2.78M | -2.55M | -3.6M | -2.73M | -3.57M | -2.52M | -2.64M | -3.45M | -3.74M | -2.68M | -3.64M |
Depreciation & Amortization | n/a | -35K | n/a | 1K | 34K | 43K | 47K | 47K | 47K | 46K | 46K | 49K | 52K | 50K | 48K | 47K | 47K |